Addiction Toxicology Case Conference - June 2026
-
Register
- Non-member - Tier I - Free!
- Non-member - Tier II - Free!
- Non-member - Tier III - Free!
- Non-member - Tier IV - Free!
- Member - Tier I - Free!
- Member - Tier II - Free!
- Member - Tier III - Free!
- Member - Tier IV - Free!
Detoxification Medicine the Black Box of the Impatient Detoxification Center
Friday, June 5, 2026
1:00-2:00pm ET
Case 1: 61 year-old M with long history of severe AUD with 1-2 month periods of sobriety followed by periods of heavy daily drinking.
Case 2: A 40 year-old homeless Puerto Rican male is admited to detox for fentanyl and synthetic cannabinoid use he uses 3-4 grams of tucey a day and also smokes 1-2 grams/day of crack cocaine.
Learning Objectives
1. To discuss the resources inpatient (non-hospital based) detoxification centers (ASAM 3.7) have available and what patients are appropriate for "detox" -list 3 patient diagnosis that would qualify
2. What type of medications are available on site and describe what an eKit is
3. List 3 of the more vulnerable aspects of detox center medicine (as per medicolegal issues)
About The Series: The ACMT/ASAM Addiction Toxicology Case Conference webinar series discusses Addiction/Toxicology cases in an interactive fashion featuring experts from Addiction Medicine, Addiction Psychiatry, and Medical Toxicology.
This webinar is free and open to the public.
Timothy J. Wiegand, MD, FACMT, DFASAM (Moderator)
Director and CEO, Toxicology Consulting
Medicine, Addiction Toxicology Consulting PLLC, ASAM President Elect (2025-2027)
Dr. Tim Wiegand is the Director of Toxicology Consults and President of CMO Medicine and Toxicology & Addiction Consulting. Board-certified in both Medical Toxicology and Addiction Medicine, Dr. Wiegand specializes in Addiction Toxicology, combining clinical practice with research, teaching, and leadership roles. He has served two terms on the Board of Directors for the American College of Medical Toxicology (ACMT) and is currently on the Board of Directors for the American Society of Addiction Medicine (ASAM). From 2023-2025, he served as Treasurer of ASAM, having previously served as Vice President on the Executive Council. From 2025-2027, Dr. Wiegand will serve as ASAM President Elect and then ASAM President (2027-2029). Dr. Wiegand founded and led the Toxicology Service at URMC until 2022, when he transitioned to Director of Addiction Medicine and Director of Addiction Medicine Consults in the Department of Emergency Medicine. He also serves as Fellowship Director for the URMC Combined Addiction Medicine Fellowship and is leading efforts to launch the URMC Medical Toxicology Fellowship, which is expected to be formally accredited by July 2023.
Gloria Baciewicz, MD (Moderator)
Addiction Psychiatrist
Strong Recovery
Since 1986, Dr. Gloria Baciewicz has specialized in the treatment of addiction. Professor of clinical psychiatry at the University of Rochester Medical Center, she serves as an addiction psychiatrist at Strong Recovery. Dr. Baciewicz is certified in addiction medicine by the American Board of Preventive Medicine and board certified in psychiatry, with added qualifications in addiction psychiatry. Dr. Baciewicz is a co-principal investigator for the University of Rochester’s Recovery Center of Excellence.
Christopher Davis, MD, MPH
Medical Director
Baden Street Settlement and Action for Better Community
Tashaba Morrison
Registered Nurse
Villa of Hope
Ayana Arnold
Licensed Practical Nurse
Villa of Hope
Key:
Complete
Next
Failed
Available
Locked